B. Isalska

1.6k total citations
21 papers, 485 citations indexed

About

B. Isalska is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, B. Isalska has authored 21 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 8 papers in Infectious Diseases and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in B. Isalska's work include Infective Endocarditis Diagnosis and Management (6 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Streptococcal Infections and Treatments (4 papers). B. Isalska is often cited by papers focused on Infective Endocarditis Diagnosis and Management (6 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Streptococcal Infections and Treatments (4 papers). B. Isalska collaborates with scholars based in United Kingdom and Türkiye. B. Isalska's co-authors include T N Stanbridge, Andrew Jones, A.K. Webb, Sait Karakurt, Volkan Korten, Nesrin Moğulkoç, Turgay Çelikel, Andrew Bentley, Tim Felton and William Hope and has published in prestigious journals such as The Lancet, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

B. Isalska

21 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Isalska United Kingdom 11 265 217 127 44 43 21 485
A. van’t Veen Netherlands 13 278 1.0× 127 0.6× 56 0.4× 40 0.9× 68 1.6× 26 494
B. Cavestri France 10 309 1.2× 255 1.2× 67 0.5× 58 1.3× 43 1.0× 15 686
Adelaida Ferrer Spain 11 295 1.1× 358 1.6× 142 1.1× 36 0.8× 35 0.8× 14 669
Rosanel Amaro Spain 13 172 0.6× 253 1.2× 66 0.5× 31 0.7× 36 0.8× 39 447
Bruno Van Herendael Belgium 16 132 0.5× 187 0.9× 88 0.7× 35 0.8× 43 1.0× 32 851
Soledad Reyes Spain 14 167 0.6× 551 2.5× 104 0.8× 32 0.7× 21 0.5× 29 778
J.R. Michie United Kingdom 7 127 0.5× 84 0.4× 105 0.8× 26 0.6× 33 0.8× 10 361
Jonas Bredtoft Boel Denmark 10 121 0.5× 190 0.9× 75 0.6× 51 1.2× 37 0.9× 39 425
Joana Saldanha Portugal 11 115 0.4× 485 2.2× 68 0.5× 29 0.7× 13 0.3× 36 619
E. Cuchí Spain 13 198 0.7× 292 1.3× 106 0.8× 43 1.0× 41 1.0× 31 681

Countries citing papers authored by B. Isalska

Since Specialization
Citations

This map shows the geographic impact of B. Isalska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Isalska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Isalska more than expected).

Fields of papers citing papers by B. Isalska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Isalska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Isalska. The network helps show where B. Isalska may publish in the future.

Co-authorship network of co-authors of B. Isalska

This figure shows the co-authorship network connecting the top 25 collaborators of B. Isalska. A scholar is included among the top collaborators of B. Isalska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Isalska. B. Isalska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Felton, Tim, Ignacio Malagon, B. Isalska, et al.. (2014). Pulmonary Penetration of Piperacillin and Tazobactam in Critically Ill Patients. Clinical Pharmacology & Therapeutics. 96(4). 438–448. 44 indexed citations
2.
Barry, Peter, B. Isalska, & Andrew Jones. (2014). Panton-Valentine Leukocidin-positive Staphylococcus aureus: a potentially significant pathogen in cystic fibrosis. Paediatric Respiratory Reviews. 15. 22–25. 3 indexed citations
3.
Isalska, B., et al.. (2014). Acidovorax oryzae Catheter-Associated Bloodstream Infection. Journal of Clinical Microbiology. 52(12). 4421–4424. 10 indexed citations
4.
Thompson, Katy‐Anne, John Pappachan, Allan Bennett, et al.. (2013). Influenza Aerosols in UK Hospitals during the H1N1 (2009) Pandemic – The Risk of Aerosol Generation during Medical Procedures. PLoS ONE. 8(2). e56278–e56278. 93 indexed citations
5.
Felton, Tim, S. A. Roberts, B. Isalska, et al.. (2012). Isolation of Aspergillus species from the airway of lung transplant recipients is associated with excess mortality. Journal of Infection. 65(4). 350–356. 22 indexed citations
6.
Thompson, Katy‐Anne, John Pappachan, Allan Bennett, et al.. (2012). Influenza aerosols in UK hospitals during the influenza H1N1 (2009–10) pandemic: air sampling in the vicinity of patients undergoing WHO-defined aerosol generating procedures. The Lancet. 380. S72–S72. 1 indexed citations
7.
Hassan, Ikrema, et al.. (2011). A quantitative descriptive study of the prevalence of carriage (colonisation) of haemolytic streptococci groups A, B, C and G in pregnancy. Journal of Obstetrics and Gynaecology. 31(3). 207–209. 16 indexed citations
8.
Flight, W.G., Ken Mutton, B. Isalska, R.J. Bright-Thomas, & Anna‐Marie Jones. (2011). S46 A comparison of three different specimen types for the diagnosis of viral respiratory infections in adults with cystic fibrosis. Thorax. 66(Suppl 4). A23–A24. 1 indexed citations
9.
Doe, Simon, B. Isalska, Angela Kearns, et al.. (2010). Patient segregation and aggressive antibiotic eradication therapy can control methicillin-resistant Staphylococcus aureus at large cystic fibrosis centres. Journal of Cystic Fibrosis. 9(2). 104–109. 33 indexed citations
10.
Isalska, B., et al.. (2010). Sternal wound infections: improvements made to reduce rates. British Journal of Nursing. 19(Sup10). S20–S29. 1 indexed citations
11.
Isalska, B., et al.. (2006). Audit of laboratory mycology services for the management of patients with fungal infections in the northwest of England. Journal of Clinical Pathology. 59(7). 759–763. 5 indexed citations
12.
Cooke, Jonathan, et al.. (2005). The use of a multidisciplinary, multifaceted team approach to optimsing antimicrobial usage at a Univeristy Teaching Hospital. Pharmacy World & Science. 27(3). 1 indexed citations
13.
Jones, Andrew, Mary Dodd, John R. W. Govan, et al.. (2004). Prospective Surveillance for Pseudomonas aeruginosa Cross-Infection at a Cystic Fibrosis Center. American Journal of Respiratory and Critical Care Medicine. 171(3). 257–260. 40 indexed citations
14.
Jones, Andrew, T N Stanbridge, B. Isalska, M Dodd, & A.K. Webb. (2001). Burkholderia gladioli:Recurrent Abscesses in a Patient with Cystic Fibrosis. Journal of Infection. 42(1). 69–71. 19 indexed citations
15.
Moğulkoç, Nesrin, et al.. (1999). Acute Purulent Exacerbation of Chronic Obstructive Pulmonary Disease and Chlamydia pneumoniae Infection. American Journal of Respiratory and Critical Care Medicine. 160(1). 349–353. 100 indexed citations
16.
Krysiak, Piotr, Adam El‐Gamel, A Rahman, et al.. (1998). Bacteremia and endocarditis following endomyocardial biopsy. Transplantation Proceedings. 30(5). 2112–2113. 5 indexed citations
17.
Stanbridge, T N & B. Isalska. (1997). Aspects of prosthetic valve endocarditis. Journal of Infection. 35(1). 1–6. 8 indexed citations
18.
Isalska, B., et al.. (1996). Electron microscopy and serological features of a patient with Q fever prosthetic valve endocarditis.. Journal of Clinical Pathology. 49(8). 679–681. 4 indexed citations
19.
Isalska, B. & T N Stanbridge. (1988). Fluconazole in the treatment of candidal prosthetic valve endocarditis.. BMJ. 297(6642). 178–179. 55 indexed citations
20.
Hardy, C., et al.. (1988). Atraumatic suppurative mediastinitis and purulent pericarditis due to Eikenella corrodens.. Thorax. 43(6). 494–495. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. van’t Veen Breakdown of academic impact, for papers by B. Cavestri Breakdown of academic impact, for papers by Adelaida Ferrer Breakdown of academic impact, for papers by Rosanel Amaro Breakdown of academic impact, for papers by Bruno Van Herendael Breakdown of academic impact, for papers by Soledad Reyes Breakdown of academic impact, for papers by J.R. Michie Breakdown of academic impact, for papers by Jonas Bredtoft Boel Breakdown of academic impact, for papers by Joana Saldanha Breakdown of academic impact, for papers by E. Cuchí
Rankless by CCL
2026